RŌNIN V6 · ON THE LABEL AT ROW 07 OF 40
Rhodiola Rosea.
Root, ≥3% rosavins, ≥1% salidroside. In Rōnin at 350 mg per serving - published to the milligram, tested every batch.
350 mgPER SERVING · 30 SERVINGS PER POUCH
AS PRINTED ON THE LABEL
- FORM
- Root
- DOSE PER SERVING
- 350 mg
- STANDARDISATION
- ≥3% rosavins, ≥1% salidroside
- GROUP
- Cognitive, Stress & Adaptogens
WHY IT’S IN
Stress and fatigue, at the full trial dose.
Rhodiola is in at 350 mg of root extract, standardised to ≥3% rosavins and ≥1% salidroside - the specification used in the studies we cite. The dose on the label is the dose in the trials.
THE RESEARCH · 4 PEER-REVIEWED PAPERS
Peer-reviewed. Or it is not on the page.
Human research supporting this ingredient at this dose. Every entry names its journal, carries its PubMed ID, and links to the source.
- 01PMID 19016404
A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
Olsson EM, et al. (2009). Planta Med. 75(2):105–12.
READ ON PUBMED → - 02PMID 12725561
A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work.
Shevtsov VA, et al. (2003). Phytomedicine. 10(2–3):95–105.
READ ON PUBMED → - 03PMID 22643043
Rhodiola rosea for physical and mental fatigue: a systematic review.
Ishaque S, et al. (2012). BMC Complement Altern Med. 12:70.
READ ON PUBMED → - 04PMID 29325481
Stress management and the role of Rhodiola rosea: a review.
Anghelescu IG, et al. (2018). Int J Psychiatry Clin Pract. 22(4):242–52.
READ ON PUBMED →
REFERENCES VERIFIED AGAINST NCBI · TITLES AS PUBLISHED
Browse the full research library →WORKS ALONGSIDE · SAME LABEL GROUP
THE HONEST LIMITS
We publish the dose and the studies, and we claim nothing beyond them. If the evidence changes, this page changes.